These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26563630)

  • 1. How to integrate research evidence on patient preferences in pharmaceutical coverage decisions and clinical practice guidelines: A qualitative study among Dutch stakeholders.
    Utens CM; Dirksen CD; van der Weijden T; Joore MA
    Health Policy; 2016 Jan; 120(1):120-8. PubMed ID: 26563630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating evidence on patient preferences in healthcare policy decisions: protocol of the patient-VIP study.
    Dirksen CD; Utens CM; Joore MA; van Barneveld TA; Boer B; Dreesens DH; van Laarhoven H; Smit C; Stiggelbout AM; van der Weijden T
    Implement Sci; 2013 Jun; 8():64. PubMed ID: 23758977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of research evidence on patient preferences in pharmaceutical coverage decisions and clinical practice guideline development: exploratory study into current state of play and potential barriers.
    Utens CM; van der Weijden T; Joore MA; Dirksen CD
    BMC Health Serv Res; 2014 Nov; 14():540. PubMed ID: 25385145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of research evidence on patient preferences in health care decision-making: issues, controversies and moving forward.
    Dirksen CD
    Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):785-94. PubMed ID: 25135194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to integrate individual patient values and preferences in clinical practice guidelines? A research protocol.
    van der Weijden T; Légaré F; Boivin A; Burgers JS; van Veenendaal H; Stiggelbout AM; Faber M; Elwyn G
    Implement Sci; 2010 Feb; 5():10. PubMed ID: 20205815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of patient preferences in clinical practice guidelines: a multiple methods study using guidelines from oncology as a case.
    Gärtner FR; Portielje JE; Langendam M; Hairwassers D; Agoritsas T; Gijsen B; Liefers GJ; Pieterse AH; Stiggelbout AM
    BMJ Open; 2019 Dec; 9(12):e032483. PubMed ID: 31811009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating values and consumer involvement in guidelines with the patient at the center: article 8 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Kelson M; Akl EA; Bastian H; Cluzeau F; Curtis JR; Guyatt G; Montori VM; Oliver S; Schünemann HJ;
    Proc Am Thorac Soc; 2012 Dec; 9(5):262-8. PubMed ID: 23256169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach.
    Zhang Y; Coello PA; Brożek J; Wiercioch W; Etxeandia-Ikobaltzeta I; Akl EA; Meerpohl JJ; Alhazzani W; Carrasco-Labra A; Morgan RL; Mustafa RA; Riva JJ; Moore A; Yepes-Nuñez JJ; Cuello-Garcia C; AlRayees Z; Manja V; Falavigna M; Neumann I; Brignardello-Petersen R; Santesso N; Rochwerg B; Darzi A; Rojas MX; Adi Y; Bollig C; Waziry R; Schünemann HJ
    Health Qual Life Outcomes; 2017 May; 15(1):52. PubMed ID: 28460638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA.
    Janssens R; Russo S; van Overbeeke E; Whichello C; Harding S; Kübler J; Juhaeri J; Bywall KS; Comanescu A; Hueber A; Englbrecht M; Nikolenko N; Pravettoni G; Simoens S; Stevens H; Hermann R; Levitan B; Cleemput I; de Bekker-Grob E; Veldwijk J; Huys I
    Patient; 2019 Oct; 12(5):513-526. PubMed ID: 31222436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluations of health technologies in Dutch healthcare decision-making: a qualitative study of the current and potential use, barriers, and facilitators.
    Roseboom KJ; van Dongen JM; Tompa E; van Tulder MW; Bosmans JE
    BMC Health Serv Res; 2017 Jan; 17(1):89. PubMed ID: 28126005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vexing problem of defining the meaning, role and measurement of values in treatment decision-making.
    Charles C; Gafni A
    J Comp Eff Res; 2014 Mar; 3(2):197-209. PubMed ID: 24645693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited role of patient input in specialty drug coverage policies.
    D'Cruz B; Graff JS; Panzer AD; Chambers JD
    J Manag Care Spec Pharm; 2021 Aug; 27(8):1067-1076. PubMed ID: 34337996
    [No Abstract]   [Full Text] [Related]  

  • 13. Moving from evidence to developing recommendations in guidelines: article 11 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Schünemann HJ; Oxman AD; Akl EA; Brozek JL; Montori VM; Heffner J; Hill S; Woodhead M; Campos-Outcalt D; Alderson P; Woitalla T; Puhan MA; Falck-Ytter Y; Bousquet J; Guyatt G;
    Proc Am Thorac Soc; 2012 Dec; 9(5):282-92. PubMed ID: 23256172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physician perspectives on the impact of patient preferences and the role of next-of-kin of patients in evidence-based decision-making: A qualitative interview study from oncology].
    Salloch S; Otte IC; Reinacher-Schick A; Vollmann J
    Z Evid Fortbild Qual Gesundhwes; 2018 Apr; 131-132():46-52. PubMed ID: 29544714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers encountered during the implementation of a policy guideline on the vaccination of health care workers during the 2013-2014 measles outbreak in the Netherlands: a qualitative study.
    Borggreve SJ; Timen A
    BMC Res Notes; 2015 Dec; 8():780. PubMed ID: 26667824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stakeholders apply the GRADE evidence-to-decision framework to facilitate coverage decisions.
    Dahm P; Oxman AD; Djulbegovic B; Guyatt GH; Murad MH; Amato L; Parmelli E; Davoli M; Morgan RL; Mustafa RA; Sultan S; Falck-Ytter Y; Akl EA; Schünemann HJ
    J Clin Epidemiol; 2017 Jun; 86():129-139. PubMed ID: 28377194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decision technologies as normative instruments: exposing the values within.
    Boivin A; Légaré F; Lehoux P
    Patient Educ Couns; 2008 Dec; 73(3):426-30. PubMed ID: 18774669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Value of Information in Healthcare Decision Making: Exploring Multiple Perspectives.
    Bindels J; Ramaekers B; Ramos IC; Mohseninejad L; Knies S; Grutters J; Postma M; Al M; Feenstra T; Joore M
    Pharmacoeconomics; 2016 Mar; 34(3):315-22. PubMed ID: 26578403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring approaches to identify, incorporate and report patient preferences in clinical guidelines: Qualitative interviews with guideline developers.
    Kim C; Berta WB; Gagliardi AR
    Patient Educ Couns; 2021 Apr; 104(4):703-708. PubMed ID: 33059950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An empirical study of patient participation in guideline development: exploring the potential for articulating patient knowledge in evidence-based epistemic settings.
    van de Bovenkamp HM; Zuiderent-Jerak T
    Health Expect; 2015 Oct; 18(5):942-55. PubMed ID: 23634973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.